NEW YORK (GenomeWeb News) –The Ben & Catherine Ivy Foundation has awarded the Translational Genomics Research Institute $10 million to conduct genomics research into glioblastoma, TGen announced today.

The funding will support two five-year, $5 million projects: one looking into why some glioblastoma multiforme (GBM) patients survive beyond the average survival time, the other investigating new drugs that might extend the survival of GBM patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.